EUVIMED · CrossrefJournal
Expert Opinion on Emerging Drugs
ISSN 1472-8214 · Informa UK Limited
Latest articles
Nucleic acid-based and small-molecule therapies for lipoprotein(a) lowering: what the trials teach us and what they do not
PROTAC degraders for lymphoid malignancies — current status and future directions
Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs
Drug discovery progress in targeting the renin–angiotensin–aldosterone system for heart failure
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies
Early investigational agents for the treatment of rosacea: drugs in phase II and III clinical development
Injectable, oral, gene-based, and vaccine-driven PCSK9-targeted therapies: emerging clinical insights shaping the future of hypercholesterolemia management
Emerging microbiome-based therapies for atopic dermatitis: clinical insights and future development
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapies
Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground?
Emerging pharmacotherapies in Gaucher disease
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
What can we expect from a combination of datopotamab deruxtecan, carboplatin, and pembrolizumab for brain metastases from non-small cell lung cancer?
Exploring the latest emerging drugs for the treatment of sickle cell disease
Targeting the gut microbiota as a treatment for obesity and cancer cachexia
Gene therapy for wet AMD: a paradigm shift in the standard of care
Emerging treatments for sarcoma: from 2024 onward
Emerging drugs for the treatment of herpetic keratitis
Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials
Cannabinoid treatment for the symptoms of autism spectrum disorder
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention
Apomorphine for Parkinson’s disease: pharmacologic and clinical considerations
Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?
Emerging oral drug options for ulcerative colitis
Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials
Emerging antiviral therapies and drugs for the treatment of influenza
Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer
Emerging drugs for the treatment of cutaneous T-cell lymphoma
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer
EUVIMED